EMPYEMA
Clinical trials for EMPYEMA explained in plain language.
Never miss a new study
Get alerted when new EMPYEMA trials appear
Sign up with your email to follow new studies for EMPYEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail could simplify treatment for dangerous lung lining infection
Disease control Recruiting nowThis study tests two different drug combinations for pleural infection, a serious infection of the lung lining that often requires surgery. The standard treatment uses two drugs (alteplase and DNase) given through a chest tube. This trial compares that to a new combination using …
Matched conditions: EMPYEMA
Sponsor: National University of Malaysia • Aim: Disease control
Last updated Jul 01, 2026 23:00 UTC
-
Could a single daily dose beat a double for lung infection treatment?
Symptom relief Recruiting nowThis study tests whether giving medication once a day through a chest tube works as well as giving it twice a day for people with serious infections around the lungs. Participants are adults already in the hospital with a chest tube draining infected fluid. They will be randomly …
Matched conditions: EMPYEMA
Phase: PHASE4 • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Scientists create fluid bank to unlock secrets of lung disease
Knowledge-focused Recruiting nowThis study collects pleural fluid (fluid around the lungs) and medical information from patients with known or suspected lung cancer or lung infections. The goal is to build a registry of samples that researchers can use to develop better tests and treatments in the future. Parti…
Matched conditions: EMPYEMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC